Intérêt du dosage de l’antigène galactomannane dans le diagnostic et le suivi de l’histoplasmose disséminée à Histoplasma capsulatum var. duboisii au cours du VIH : enseignement à partir d’un cas clinique
Authors:
- 1 June 2014
- journal article
- case report
- Published by Elsevier in Journal of Medical Mycology
- Vol. 24 (2) , 166-170
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Comparison of PCR protocols for detecting Histoplasma capsulatum DNA through a multicenter studyRevista Iberoamericana de Micologia, 2013
- False positive galactomannan Platelia due to piperacillin-tazobactamMedecine Et Maladies Infectieuses, 2012
- Histoplasmosis and Paracoccidioidomycosis in a Non‐Endemic Area: A Review of Cases and DiagnosisJournal of Travel Medicine, 2010
- The interaction between piperacillin/tazobactam and assays for Aspergillus galactomannan and 1,3-beta-d-glucan in patients without risk factors for invasive fungal infectionsInfection, 2010
- Diagnosis of histoplasmosis in immunosuppressed patientsCurrent Opinion in Infectious Diseases, 2008
- Histoplasmosis as a cause for a positive Fungitell™ (1→3)-β-D-glucan testMedical Mycology, 2008
- False-positive Aspergillus galactomannan (GM) assay in histoplasmosisJournal of Infection, 2008
- Literature Review and Case Histories of Histoplasma capsulatum var. duboisii Infections in HIV-infected PatientsEmerging Infectious Diseases, 2007
- Update on the contribution of galactomannan for the diagnosis of invasive aspergillosisMycopathologia, 2007
- PCR Assay for Identification of Histoplasma capsulatum Based on the Nucleotide Sequence of the M AntigenJournal of Clinical Microbiology, 2003